Swedish researchers have developed a novel tool that can predict the risk level of nerve damage in each individual from breast cancer treatment. 

While once deadly cancer is becoming treatable, many women treated for breast cancer using taxanes -- a chemotherapy drug used to prevent breast cancer recurrence -- often experience side effects in the nervous system.